Although the average size of the MMTV-Hras/p53R172H/R172H tumors at the initiation of treatment was larger than that of the MMTV-Hras/p53-/- tumors, the overall shape of the tumor response curves was nearly superimposable. The gene discussed is HRAS; the disease is neoplasm.